RecruitingNot ApplicableNCT05742880
Effect of Face Masks on Pulmonary Function in Patients With COPD
Sponsor
Medical University of Vienna
Enrollment
40 participants
Start Date
Nov 1, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
Given the heightened vulnerability of COPD patients to severe illness upon SARS-CoV-2 infection, precautions like mask-wearing are deemed crucial. Yet, mask-wearing can exacerbate breathlessness and discomfort in this demographic. This study aims to assess the effects of wearing a face mask during 6-Minute-Walking-Tests (6-MWT) among COPD patients.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria2
- COPD Diagnosis
- Vaccinated against SARS-CoV 2
Exclusion Criteria5
- Known cardial insufficency
- Long term oxgenation therapy
- immobility
- BMI \>35
- Pregnancy
Interventions
DIAGNOSTIC_TEST6 Minute Walking Test
6 Minute walking test
DIAGNOSTIC_TESTBlood gas analysis
Blood gas analyisis
PROCEDUREWearing a Surgical Facemask
Wearing a Surgical Facemask
PROCEDUREWearing a FFP2- Facemask
Wearing a FFP2- Facemask
PROCEDUREWearing no Mask
Wearing no Mask
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05742880
Related Trials
Home Hospital for Suddenly Ill Adults
NCT035242222 locations
Assess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis
NCT0724557612 locations
A Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema
NCT070863392 locations
Effect of Telenursing on Oral Health
NCT074622211 location
Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry
NCT069749811 location